“Vascular age” is an intuitive but methodologically inconsistent label. Some clinical tools convert total cardiovascular risk or a validated stiffness measure into an age equivalent. MaxPulse does not directly measure either, and its current report does not provide arterial age in years. It derives proprietary waveform categories and AE/PE scores from fingertip PPG/APG. This article explains why those outputs are device-specific vascular context rather than a clinical stiffness measurement.
Vascular age has no single standardized definition. It may describe an age equivalent of overall cardiovascular risk, a comparison of a validated stiffness measure with a reference population, or a proprietary manufacturer label. Results from those methods are not interchangeable.
Arteries generally become stiffer with age and pulse-wave velocity rises. A fingertip PPG waveform, however, is also shaped by wave reflections, blood pressure, heart rate, peripheral vascular tone, temperature and signal quality. One fingertip recording therefore does not directly measure the mechanical stiffness of the whole arterial tree.
The current MaxPulse report does not provide a clinically standardized vascular age in years. Its categories can be compared cautiously within the same device under similar conditions, alongside blood pressure and established risk factors; the clinical meaning of a change in those categories has not been established.
MaxPulse uses photoplethysmography (PPG), optical sensing of relative blood-volume changes at the fingertip. From that signal it creates accelerated plethysmography (APG), the second derivative of the PPG waveform.
It derives proprietary waveform categories and AE/PE scores from wave shape and ratios. This is not a two-site pulse-wave velocity measurement, a pressure waveform or a direct conversion into age. Treat it as output from a specific algorithm rather than a physical measurement of the arterial wall.
For a deeper look at how these indices are calculated from pulse wave shape and what the a-e waves actually mean, see the dedicated article on accelerated plethysmography and pulse wave – here the focus is on what to do with the resulting number.
You may encounter the term in risk calculators, some clinical methods and consumer devices. MaxPulse is sometimes placed in this group because of its APG vascular output, but its current report does not directly provide age in years.
A pharmacy or consumer quick-test may use a cuff, PPG, an estimated pulse wave or a risk calculator depending on the device; the label alone does not reveal the method. Wearables usually rely on optical PPG and a manufacturer-specific algorithm. MaxPulse uses fingertip PPG/APG and its own classification process.
Different numbers between methods do not mean one device is lying and another is right; they may represent different constructs. Carotid-femoral pulse-wave velocity (cf-PWV) is the clinical reference method for arterial stiffness. MaxPulse does not measure cf-PWV.
If you follow a device-specific trend, use one method and one device under similar conditions. An age estimate from a pharmacy cannot be directly compared with a smartwatch or Max Pulse score; a change within one device does not itself prove a change in arterial stiffness.
| Method | Measurement principle | Measurement site | Typical use case | Level of clinical validation |
|---|---|---|---|---|
| Pharmacy quick-test | Depends on the device: cuff, PPG, estimated PWV or a risk model | Device dependent | One-off orientation screening at a pharmacy | Cannot be inferred without the exact method and validation |
| Smartwatch / fitness band | Simplified optical PPG and the manufacturer's proprietary algorithm | Wrist | Ongoing wellness tracking | Varies by device, output and published validation |
| Max Pulse (mojeinbody) | PPG and accelerated plethysmography (APG) within a comprehensive screening | Fingertip | Tracking trend over time alongside blood pressure, HRV and body composition | Orientation-style – a wellness tool, not a clinical gold standard |
A less favourable APG category is a prompt to check measurement conditions and the broader context: blood pressure, smoking, activity, established cardiovascular risk factors and symptoms. It is not proof of “old arteries.”
Discuss repeatedly high blood pressure or a significant family history with a clinician regardless of the APG category. New or severe chest pain or shortness of breath needs urgent medical attention; do not wait for another Max Pulse measurement.
A single score has limited meaning. Repeated measurements under similar conditions may show whether the device categories shift or fluctuate, but they cannot by themselves confirm improvement or deterioration in vascular health.
APG output makes the most sense alongside blood pressure, established risk factors and measurement conditions. Even a less favourable APG category together with lower pulse variability does not establish a vascular diagnosis.
Grip strength and body composition belong in the picture too. Muscle mass, body fat percentage, and regular physical activity are closely tied to cardiovascular health, so results from InGrip and InBody analysis add another dimension to vascular age.
That is why the portal keeps the APG output beside the other measurements without treating it as a clinical vascular-age clock.
Mechanical arterial properties usually do not change from day to day, but fingertip APG can move with blood pressure, pulse, temperature and peripheral vascular tone. Chasing every short-term change is therefore not useful.
There is no established clinical interval for following this proprietary APG score. If you choose to compare it for orientation, spacing tests by weeks or months is more practical than chasing daily fluctuations; timing should fit the reason for testing and your health context.
Consistent measurement conditions – a similar time of day, resting beforehand, and a similar hydration state – make results more comparable over time. Even such a trend is not a validated measure of change in arterial stiffness.
Misconception one: every value called vascular age measures the same thing. In reality it may come from a risk model, a pulse-wave method or a proprietary algorithm.
Misconception two: a favourable APG category rules out cardiovascular risk. MaxPulse does not replace blood pressure, laboratory values, history or clinical assessment.
Misconception three: different devices should give the same number, and if they don't, something is wrong. Methods differ in measurement principle and algorithm, so different numbers are expected – what's worth comparing is how the number moves over time within one and the same method.
About the measurement
The main page about HRV, vascular signal, stress and autonomic balance.
More reading
FAQ
Vascular age is a broad label for an age equivalent derived by different methods. The current MaxPulse report does not provide a standardized age in years; it creates proprietary categories and scores from fingertip APG.
The current MaxPulse report does not provide standardized vascular age in years. It derives proprietary categories and AE/PE scores from fingertip PPG/APG; these do not replace carotid-femoral pulse-wave velocity or another clinical assessment of arterial stiffness.
A label such as vascular age may come from different data and algorithms. MaxPulse uses fingertip PPG/APG and its current report does not provide an age in years. Its score therefore cannot be compared one-to-one with an age estimate from another system.
It does not determine disease or risk on its own. Check measurement conditions and trend, and focus on blood pressure and established risk factors. Seek clinical advice for repeated high blood pressure, significant family history or symptoms regardless of the APG category.
Exercise, not smoking and blood-pressure control support cardiovascular health, but a change in a proprietary APG category does not by itself prove a change in mechanical arterial stiffness. Follow established risk factors and keep measurement conditions comparable.
MaxPulse does not add a clinically measured age of the arteries. It adds proprietary APG context that should be followed only within the same device and read alongside blood pressure, established risk factors and any symptoms.
